None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who visit Asan Medical Center for osteoporosis and give the informed consent. Patients with measurement of bone mineral density (BMD) for osteoporosis (Classification of case / control group by BMD result) Wahout peroid: Two years using agents more than 6 months against osteoporosis
Exclusion criteria
Exclusion criteria: 1. Subjects within wash-out period 2. Secondary osteoporosis: Disorders strongly associated with osteoporosis. These include rheumatoid arthritis, untreated long-standing hyperthyroidism or Graves' disease, chronic liver disease, hyperparathyroidism, and parathyroid adenoma 3. Other conditions were not suitable in cohort study: Chronic renal failure, active malignany, and transplantation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association between novel discovered SNP with osteoporosis or osteoporotic fracture risk | — |
Secondary
| Measure | Time frame |
|---|---|
| Association between novel discovered SNP with bone mineral density ;Association between novel discovered SNP with changes of bone mineral density ;Effect of novel discovered SNP on changes of bone mineral density according to treatment methods | — |
Countries
Korea, Republic of
Contacts
Asan Medical Center